Connective tissue disease: Difference between revisions

Jump to navigation Jump to search
Vanbot (talk | contribs)
m Robot: Changing Category:Diseases to Category:Disease
 
 
(2 intermediate revisions by 2 users not shown)
Line 14: Line 14:
}}
}}
{{SI}}
{{SI}}
{{EH}}
 
==Overview==
==Overview==
A '''connective tissue disease''' is any disease that has the connective tissues of the body as a primary target of pathology.  [[Connective tissue]] is any type of  [[biological tissue]] with an extensive [[extracellular matrix]] that supports, binds together, and protects [[organ (anatomy)|organ]]s. These tissues form a framework, or matrix, for the body, and are composed of two major structural protein molecules, collagen and elastin. There are many different types of collagen protein in each of the body's tissues. Elastin has the capability of stretching and returning to its original length - like a spring or rubber band. Elastin is the major component of ligaments (tissues that attach bone to bone) and skin.  In patients with connective tissue disease, it is common for collagen and elastin to become injured by inflammation. Many connective tissue diseases feature abnormal immune system activity with inflammation in tissues as a result of an immune system that is directed against one's own body tissues (autoimmunity).
A '''connective tissue disease''' is any disease that has the connective tissues of the body as a primary target of pathology.  [[Connective tissue]] is any type of  [[biological tissue]] with an extensive [[extracellular matrix]] that supports, binds together, and protects [[organ (anatomy)|organ]]s. These tissues form a framework, or matrix, for the body, and are composed of two major structural protein molecules, collagen and elastin. There are many different types of collagen protein in each of the body's tissues. Elastin has the capability of stretching and returning to its original length - like a spring or rubber band. Elastin is the major component of ligaments (tissues that attach bone to bone) and skin.  In patients with connective tissue disease, it is common for collagen and elastin to become injured by inflammation. Many connective tissue diseases feature abnormal immune system activity with inflammation in tissues as a result of an immune system that is directed against one's own body tissues (autoimmunity).
Line 20: Line 20:
Diseases in which inflammation or weakness of collagen tends to occur are also referred to as collagen diseases. Collagen vascular disease is a somewhat antiquated term used to describe diseases of the connective tissues that typically include diseases which can be (but are not necessarily) associated with blood vessel abnormalities.
Diseases in which inflammation or weakness of collagen tends to occur are also referred to as collagen diseases. Collagen vascular disease is a somewhat antiquated term used to describe diseases of the connective tissues that typically include diseases which can be (but are not necessarily) associated with blood vessel abnormalities.


Connective tissue diseases can have strong or weak inheritance risks, and can also be caused by environmental factors.
Connective tissue diseases can have strong or weak inheritance risks, and can also be caused by environmental factors. Some signs, such as red skin at the base of the nails, can signify connective tissue disorders.


==Heritable Connective Tissue Disorders==
==Heritable Connective Tissue Disorders==
Line 38: Line 38:
* [[Mixed Connective Tissue Disease]] - Mixed connective-tissue disease (MCTD) is a disorder in which features of various connective-tissue diseases (CTDs) such as systemic lupus erythematosus (SLE); systemic sclerosis (SSc); dermatomyositis (DM); polymyositis (PM); and, occasionally, Sjögren syndrome can coexist and overlap. The course of the disease is chronic and usually milder than other CTDs. In most cases, MCTD is considered an intermediate stage of a disease that eventually becomes either SLE or Scleroderma.
* [[Mixed Connective Tissue Disease]] - Mixed connective-tissue disease (MCTD) is a disorder in which features of various connective-tissue diseases (CTDs) such as systemic lupus erythematosus (SLE); systemic sclerosis (SSc); dermatomyositis (DM); polymyositis (PM); and, occasionally, Sjögren syndrome can coexist and overlap. The course of the disease is chronic and usually milder than other CTDs. In most cases, MCTD is considered an intermediate stage of a disease that eventually becomes either SLE or Scleroderma.


==External links==
* [http://www.merck.com/mrkshared/mmanual/section5/sec5.jsp Merck Manual: Musculoskeletal and connective tissue disorders]
* [http://www.merck.com/mrkshared/mmanual/section19/chapter270/270d.jsp Merck Manual: Inherited connective tissue disorders]
* [http://www.arthritis.org/conditions/DiseaseCenter/myositis.asp Arthritis Foundation]
* [http://www.myositis.org/about_myositis/inclusion-body_myositis.cfm The Myositis Foundation]


[[de:Kollagenose]]
[[de:Kollagenose]]

Latest revision as of 16:45, 11 August 2013

Connective tissue disease
MeSH D003240

WikiDoc Resources for Connective tissue disease

Articles

Most recent articles on Connective tissue disease

Most cited articles on Connective tissue disease

Review articles on Connective tissue disease

Articles on Connective tissue disease in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Connective tissue disease

Images of Connective tissue disease

Photos of Connective tissue disease

Podcasts & MP3s on Connective tissue disease

Videos on Connective tissue disease

Evidence Based Medicine

Cochrane Collaboration on Connective tissue disease

Bandolier on Connective tissue disease

TRIP on Connective tissue disease

Clinical Trials

Ongoing Trials on Connective tissue disease at Clinical Trials.gov

Trial results on Connective tissue disease

Clinical Trials on Connective tissue disease at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Connective tissue disease

NICE Guidance on Connective tissue disease

NHS PRODIGY Guidance

FDA on Connective tissue disease

CDC on Connective tissue disease

Books

Books on Connective tissue disease

News

Connective tissue disease in the news

Be alerted to news on Connective tissue disease

News trends on Connective tissue disease

Commentary

Blogs on Connective tissue disease

Definitions

Definitions of Connective tissue disease

Patient Resources / Community

Patient resources on Connective tissue disease

Discussion groups on Connective tissue disease

Patient Handouts on Connective tissue disease

Directions to Hospitals Treating Connective tissue disease

Risk calculators and risk factors for Connective tissue disease

Healthcare Provider Resources

Symptoms of Connective tissue disease

Causes & Risk Factors for Connective tissue disease

Diagnostic studies for Connective tissue disease

Treatment of Connective tissue disease

Continuing Medical Education (CME)

CME Programs on Connective tissue disease

International

Connective tissue disease en Espanol

Connective tissue disease en Francais

Business

Connective tissue disease in the Marketplace

Patents on Connective tissue disease

Experimental / Informatics

List of terms related to Connective tissue disease

Overview

A connective tissue disease is any disease that has the connective tissues of the body as a primary target of pathology. Connective tissue is any type of biological tissue with an extensive extracellular matrix that supports, binds together, and protects organs. These tissues form a framework, or matrix, for the body, and are composed of two major structural protein molecules, collagen and elastin. There are many different types of collagen protein in each of the body's tissues. Elastin has the capability of stretching and returning to its original length - like a spring or rubber band. Elastin is the major component of ligaments (tissues that attach bone to bone) and skin. In patients with connective tissue disease, it is common for collagen and elastin to become injured by inflammation. Many connective tissue diseases feature abnormal immune system activity with inflammation in tissues as a result of an immune system that is directed against one's own body tissues (autoimmunity).

Diseases in which inflammation or weakness of collagen tends to occur are also referred to as collagen diseases. Collagen vascular disease is a somewhat antiquated term used to describe diseases of the connective tissues that typically include diseases which can be (but are not necessarily) associated with blood vessel abnormalities.

Connective tissue diseases can have strong or weak inheritance risks, and can also be caused by environmental factors. Some signs, such as red skin at the base of the nails, can signify connective tissue disorders.

Heritable Connective Tissue Disorders

  • Marfan syndrome - a genetic disease causing abnormal fibrillin.
  • Ehlers-Danlos syndrome - causes progressive deterioration of collagens, with different EDS types affecting different sites in the body, such as joints, heart valves, organ walls, arterial walls
  • Osteogenesis imperfecta (brittle bone disease) - caused by insufficient production of good quality collagen to produce healthy, strong bones.

Weakly or Non-Heritable Connective Tissue Disorders

These are the autoimmune CTDs, where the cause is unknown but may have both genetic and environmental links. Weaker genetic factors may create a predisposition towards developing these autoimmune diseases. They are characterized as a group by the presence of spontaneous overactivity of the immune system which results in the production of extra antibodies into the circulation. The classic collagen vascular have a "classic" presentation with typical findings that doctors can recognize during an examination. Each also has "classic" blood test abnormalities and abnormal antibody patterns. However, each of these diseases can evolve slowly or rapidly from very subtle abnormalities before demonstrating the classic features which help in the diagnosis. The classic collagen vascular diseases include:

  • Scurvy - caused by a dietary deficiency in vitamin C, leading to abnormal collagen.
  • Systemic Lupus Erythematosus (SLE) - An inflammation of the connective tissues, SLE can afflict every organ system. It is up to nine times more common in women than men and strikes black women three times as often as white women. The condition is aggravated by sunlight.
  • Rheumatoid Arthritis - Rheumatoid arthritis is a systemic disorder in which immune cells attack and inflame the membrane around joints. It also can affect the heart, lungs, and eyes. Of the estimated 2.1 million Americans with rheumatoid arthritis, approximately 1.5 million (71 percent) are women.
  • Scleroderma - an activation of immune cells which produces scar tissue in the skin, internal organs, and small blood vessels. It affects women three times more often than men overall, but increases to a rate 15 times greater for women during childbearing years, and appears to be more common among black women.
  • Sjögren's syndrome - also called Sjögren's disease, is a chronic, slowly progressing inability to secrete saliva and tears. It can occur alone or with rheumatoid arthritis, scleroderma, or systemic lupus erythematosus. Nine out of 10 cases occur in women, most often at or around mid-life.
  • Myositis - Myositis involves inflammation that results in damage to muscle fibers and skin. Myositis is a term that describes several illnesses including polymyositis, dermatomyositis and inclusion body myositis. Polymyositis involves inflammation of the muscles and can affect many parts of the body. Dermatomyositis involves inflammation of skin. Inclusion myositis is similar to polymositis, but its onset is generally slower and more relentlessly progressive. All of these fall into the category of inflammatory muscle diseases - "myo" means "muscles" in Greek; "itis" means "inflamed". "Derma", which means "skin", implies the skin-related signs and symptoms that accompany the muscle inflammation of dermatomyositis.
  • Mixed Connective Tissue Disease - Mixed connective-tissue disease (MCTD) is a disorder in which features of various connective-tissue diseases (CTDs) such as systemic lupus erythematosus (SLE); systemic sclerosis (SSc); dermatomyositis (DM); polymyositis (PM); and, occasionally, Sjögren syndrome can coexist and overlap. The course of the disease is chronic and usually milder than other CTDs. In most cases, MCTD is considered an intermediate stage of a disease that eventually becomes either SLE or Scleroderma.


de:Kollagenose

Template:WikiDoc Sources